Showing results (11-20 of 952) with videos related to
Sort By:
Pageof 96
Oncotarget|November 29, 2017
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacyBrent A Williams, Arjun Datt Law, Bertrand Routy, et al.Experimental Hematology|June 14, 2002
Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantationSimon J Bubnic, Armand KeatingCurrent Opinion in Hematology|July 16, 2025
Mesenchymal stromal cells: an updateOlivia J Lee, Armand KeatingGerontology|September 18, 2008
Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-reviewBrent A Williams, Armand KeatingExpert Review of Anticancer Therapy|June 25, 2003
Advances in targeted therapy for chronic myeloid leukemiaKaren W L Yee, Armand KeatingHuman Gene Therapy|February 4, 2011
Mesenchymal stromal cells for graft-versus-host diseaseJakub Tolar, Pierre Villeneuve, Armand KeatingBlood|January 26, 2011
How I treat relapsed and refractory Hodgkin lymphomaJohn Kuruvilla, Armand Keating, Michael CrumpCurrent Opinion in Organ Transplantation|December 23, 2016
Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repairAgata Bartczak, Ian McGilvray, Armand KeatingExpert Review of Hematology|November 25, 2010
Older patients with acute myeloid leukemiaKaren W L Yee, Armand KeatingMolecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Prodrugs and prodrug-activated systems in gene therapySemira Sheikh, Daniel Ernst, Armand KeatingPageof 96